ANGELA THOMAS: Open Payments
NPI 1427474600 · REDDING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,480 in 96 payments from 11 companies in 2025. Trend: 2023 $2,002 · 2024 $1,653 · 2025 $2,480
Food & beverage: $2,480
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 17 | $704 |
| ABBVIE INC. | 26 | $427 |
| Janssen Biotech, Inc. | 12 | $334 |
| Ipsen Biopharmaceuticals, Inc | 6 | $268 |
| Ardelyx, Inc. | 9 | $207 |
| Lilly USA, LLC | 6 | $172 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $166 |
| PFIZER INC. | 5 | $84 |
| Intercept Pharmaceuticals, Inc. | 4 | $72 |
| Gilead Sciences, Inc. | 1 | $24 |
Products named: REZDIFFRA, TREMFYA, IQIRVO, IBSRELA, OMVOH, ENTYVIO, RINVOQ, LINZESS.
Industry payments across CA — which companies pay providers there.
